Medipyxis
blog7 min read

Wound Care Partnership Agreement: Essential Terms Guide

Essential terms for wound care partnership agreements covering buy-in, buy-out, compensation splits, decision authority, non-compete clauses, and dissolution planning.

D

Damon Ebanks

Medipyxis

Wound Care Partnership Agreement: Essential Terms Guide

Wound Care Partnership Agreement: The Terms That Prevent Lawsuits

Every wound care partnership starts with optimism and shared vision. Partners agree they will figure out the details later because right now they are focused on building the practice. Then revenue grows, workloads diverge, clinical philosophies clash, or one partner wants to exit. Without a wound care partnership agreement that addresses these scenarios in advance, the resolution is expensive, adversarial, and sometimes practice-ending.

This guide covers the essential terms your partnership agreement must include. It is not a substitute for a healthcare attorney, but it prepares you to have a productive conversation with one.


Partnership Structure and Ownership

The first section of any partnership agreement defines who owns what and how ownership can change. For wound care practices, this involves several specific considerations.

Ownership percentages. Equal partnership (50/50) is simple but creates a structural problem: deadlocked decisions. Most experienced healthcare attorneys recommend either unequal splits (51/49, 60/40) with defined majority-decision categories, or equal splits with a tie-breaking mechanism such as mediation or a designated deciding vote.

Capital contributions. Define what each partner contributes at formation. This includes cash, equipment, existing patient relationships, payer contracts, and sweat equity. Everything of value must be documented and agreed upon because these contributions form the basis for buy-out calculations later.

Ownership classes. Some wound care partnerships distinguish between equity ownership (profit sharing and asset rights) and voting ownership (decision-making authority). A founding partner who brings the patient base and payer contracts might hold 60% equity and 50% voting rights, with the clinical partner holding 40% equity and 50% voting rights.

Entity Type Implications

Your entity type affects partnership terms significantly. An LLC operating agreement and an S-Corp shareholder agreement handle profit distributions, self-employment taxes, and partner exits differently. Choose your entity structure before drafting partnership terms, not the other way around. For a comparison of entity types, see our wound care practice legal structure guide.


Buy-In and Buy-Out Terms

This section prevents the most destructive partnership disputes: disagreements about what a partner's share is worth when someone enters or leaves.

Buy-in structure for new partners:

  • Define the buy-in price formula in advance. The most common approaches are a multiple of trailing twelve-month EBITDA, a percentage of appraised practice value, or a fixed price schedule that adjusts annually.
  • Specify the payment terms. Most new partners cannot write a check for their full buy-in. Structured payments over 3 to 5 years, funded from the new partner's share of profits, are standard.
  • Include a vesting schedule. A partner who buys in and leaves after six months should not walk away with full ownership. Two to four-year vesting with a one-year cliff protects the practice from short-tenure exits.

Buy-out triggers and mechanics:

Your agreement must address every scenario that could trigger a buy-out:

  • Voluntary departure. A partner decides to leave. The agreement specifies notice period (typically 6 to 12 months for wound care practices), valuation method, and payment timeline.
  • Death or disability. Fund this with life insurance and disability buy-out insurance. Without insurance, the remaining partner must buy out the deceased partner's estate, often at the worst possible time financially.
  • Involuntary removal. Define the circumstances under which a partner can be removed (typically for-cause events like license revocation, felony conviction, or material breach of the agreement) and the financial consequences (usually a discounted buy-out price).
  • Retirement. Set a process for planned retirement that includes transition timelines for patient relationships and referral source management.

Compensation and Profit Distribution

How partners get paid is where most day-to-day partnership friction originates. The agreement must be explicit about compensation structure.

Base compensation models:

  • Equal draw regardless of production. Works when both partners contribute similarly in clinical volume and administrative effort. Breaks down when one partner consistently out-produces the other.
  • Production-based compensation. Each partner receives a base draw plus a percentage of their personal production (collections on services they performed). This aligns effort with reward but can create competition for higher-paying procedures.
  • Hybrid model. Equal base draw (covering administrative duties, on-call, and practice management time) plus a production bonus above a defined threshold. This is the most common structure in wound care partnerships because it rewards clinical productivity while compensating the non-clinical work that both partners share.

Profit distributions. After partner compensation, remaining profits are distributed according to ownership percentage, retained for practice reinvestment, or both. Define the split between distribution and reinvestment in the agreement. A common formula is 60% distributed, 40% retained, with annual review.


Decision Authority and Management

Not every decision requires unanimous agreement. The partnership agreement should categorize decisions by authority level.

Unanimous consent required:

  • Selling the practice or a significant portion of its assets
  • Taking on debt above a defined threshold
  • Adding a new partner
  • Changing the practice's clinical scope or service lines
  • Entering or exiting a geographic market

Majority or managing partner decision:

  • Hiring and firing non-partner employees
  • Vendor selection and supply contracts below a defined dollar amount
  • Marketing spend within the annual budget
  • Day-to-day operational decisions

Individual partner authority:

  • Clinical treatment decisions for their own patients
  • Continuing education and professional development choices
  • Personal scheduling within agreed-upon availability requirements

Deadlock Resolution

When partners disagree on a decision that requires unanimous consent, the agreement must specify a resolution path. Options include mediation by a pre-selected mediator, binding arbitration, or a shotgun clause (where one partner offers to buy or sell at a named price, and the other partner chooses which side to take). Shotgun clauses are aggressive but effective at breaking deadlocks, and they incentivize fair pricing because either partner could end up on either side.


Non-Compete and Non-Solicitation Clauses

Wound care practices depend heavily on referral relationships and patient continuity. A departing partner who opens a competing practice across the street and takes the referral sources can destroy the remaining practice.

Non-compete terms: Typically restrict a departing partner from practicing wound care within a defined geographic radius (15 to 30 miles for urban markets, larger for rural) for a defined period (1 to 3 years). Enforceability varies significantly by state, so draft these with local legal counsel.

Non-solicitation terms: Separately restrict the departing partner from soliciting the practice's patients, employees, and referral sources. Non-solicitation clauses are generally more enforceable than non-competes and often more important practically.

For a comparison of solo versus group practice structures and when partnership makes strategic sense, see our guide on solo versus group wound care practice models.


Dissolution Planning

No one wants to plan for the end at the beginning, but dissolution terms drafted during a dispute are dissolution terms drafted by lawyers billing hourly while emotions run high.

Your agreement should specify:

  • How assets are liquidated and proceeds distributed
  • How outstanding liabilities (lease obligations, equipment financing, malpractice tail coverage) are allocated
  • Who retains the practice name and phone number
  • How patient records are managed and patients notified
  • How referral source relationships are transitioned
  • Wind-down timeline and responsibilities

Key Takeaways

  • Define buy-in and buy-out formulas in the original agreement. Negotiating valuations during a partner exit is adversarial by nature.
  • Fund death and disability buy-outs with insurance. Without it, the surviving partner faces a financial crisis compounded by an operational one.
  • Use a hybrid compensation model (base draw plus production bonus) to balance fairness with productivity incentives.
  • Categorize decisions by authority level. Not everything needs unanimous consent, and requiring it creates gridlock.
  • Draft dissolution terms at formation, not during the dispute. The cost of planning is a fraction of the cost of litigating.

Want to learn more about Medipyxis?

Explore how mobile wound care practices use Medipyxis to reduce denials and capture more referrals.